サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1543873

移植の世界市場

Transplantation

出版日
ページ情報
英文 232 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
移植の世界市場
出版日: 2024年08月29日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 232 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

移植の世界市場は2030年までに227億米ドルに到達

2023年に140億米ドルと推定される移植の世界市場は、2023年から2030年にかけてCAGR 7.1％で成長し、2030年には227億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである臓器移植は、CAGR 6.9％を記録し、分析期間終了時には86億米ドルに達すると予測されています。ティッシュ移植セグメントの成長率は、分析期間中CAGR 7.2％と推定されます。

米国市場は37億米ドル、中国はCAGR 11.7％で成長予測

米国の移植市場は2023年に37億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに56億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは11.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.0%と7.0%と予測されています。欧州では、ドイツがCAGR 3.8%で成長すると予測されています。

世界の移植市場- 主要動向と促進要因まとめ

移植とは何か、なぜ重要なのか？

移植とは、臓器、組織、細胞をドナーからレシピエントに移植し、損傷したり機能不全に陥ったりした身体の一部の機能を回復させる医療処置です。一般的な移植には、腎臓移植、肝臓移植、心臓移植、肺移植、骨髄移植などがあります。移植は、末期臓器不全や特定の疾患を持つ患者の命を救い、生活の質を向上させるために不可欠です。移植の成功は、ドナーとレシピエントのマッチング、免疫反応の管理、移植片の長期生存の確保にかかっています。移植技術と免疫抑制療法の進歩は、移植の成果を著しく改善し、現代医学の重要な要素となっています。

技術の進歩は市場にどのような影響を与えたか？

技術の進歩は移植市場に大きな影響を与えてきました。低侵襲手術やロボット支援手術などの手術手技の革新は、移植手術の精度と治療成績を向上させました。先進的な免疫抑制剤の開発により、移植拒絶反応の管理が強化され、移植片の生存率が向上しました。機械灌流や低温保存ソリューションなどの臓器保存・輸送技術の進歩は、ドナー臓器の生存期間を延長し、移植の成功率を高めています。さらに、再生医療や幹細胞研究により、生体工学的臓器や組織を作り出す新たな可能性が開かれ、ドナー臓器の不足に対処しています。こうした技術的進歩は、移植の適用範囲と有効性を拡大し、市場の成長を促進しています。

主要利害関係者とは？

移植市場の主要利害関係者には、移植センター、病院、臓器調達機関、製薬会社、患者などが含まれます。移植センターと病院は移植手術を行い、移植後のケアを提供するため、高品質のドナー臓器、高度な手術器具、効果的な免疫抑制療法へのアクセスを必要とします。臓器調達団体は、臓器の提供や流通を調整し、効率的で信頼できる臓器保存や輸送のソリューションを求めています。製薬会社は、移植拒絶反応を管理し転帰を改善するための免疫抑制剤やその他の治療法を開発し、強固な臨床研究開発能力を必要としています。患者は、健康と生活の質を回復するために成功した移植を頼りにしており、タイムリーで効果的な移植サービスへのアクセスを求めています。それぞれの利害関係者は、移植の複雑な課題に対処するための革新的で効果的な解決策を求めています。

移植市場の成長の原動力は？

移植市場の成長は、臓器不全の有病率の増加、移植技術の進歩、臓器移植の需要の高まりなど、いくつかの要因によって牽引されています。糖尿病、心血管疾患、肝硬変などの慢性疾患の罹患率の増加により、臓器不全が増加し、移植の需要を牽引しています。手術方法の改善や免疫抑制療法などの移植技術の進歩は、移植の成功率を高め、適格なレシピエントのプールを拡大しています。臓器提供に対する認識と受容の高まりに後押しされた臓器移植需要の高まりが、市場の成長をさらに後押ししています。さらに、移植プログラムや研究に対する政府の取り組みや資金援助が、移植市場の拡大・開拓を支えています。

調査対象企業の例（注目の118社）

  • Abbott Laboratories, Inc.
  • Acelity LP, Inc.
  • Avioq, Inc.
  • AxoGen, Inc.
  • BD Biosciences
  • BioLife Solutions Inc.
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • Carmat SA
  • Chronix Biomedical
  • Dr. Franz Kohler Chemie GmbH
  • F. Hoffmann-La Roche AG
  • GenDx
  • Histogenics Corporation
  • Illumina, Inc.
  • Luminex Corporation
  • Medipex Limited
  • Miromatrix Medical Inc.
  • Nano Dimension Ltd.
  • Organovo Holdings, Inc.
  • Ortho Clinical Diagnostics
  • Oxford Immunotec Global PLC
  • Pacific Biosciences of California, Inc.
  • Pandorum Technologies Pvt. Ltd.
  • Qiagen NV
  • Siemens Healthineers
  • SynCardia
  • Thermo Fisher Scientific, Inc.
  • Transplant Biomedicals S.L.
  • XVIVO Perfusion AB

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP15304

Global Transplantation Market to Reach US$22.7 Billion by 2030

The global market for Transplantation estimated at US$14.0 Billion in the year 2023, is expected to reach US$22.7 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. Organ transplantation, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Tissue transplantation segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 11.7% CAGR

The Transplantation market in the U.S. is estimated at US$3.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 11.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Transplantation Market - Key Trends & Drivers Summarized

What Is Transplantation and Why Is It Vital?

Transplantation is a medical procedure that involves transferring organs, tissues, or cells from a donor to a recipient to restore function in a damaged or failing body part. Common types of transplants include kidney, liver, heart, lung, and bone marrow transplants. Transplantation is vital for saving lives and improving the quality of life for patients with end-stage organ failure and certain diseases. The success of transplantation relies on matching donors and recipients, managing immune responses, and ensuring long-term graft survival. Advances in transplantation techniques and immunosuppressive therapies have significantly improved transplant outcomes, making it a critical component of modern medicine.

How Have Technological Advances Impacted the Market?

Technological advances have profoundly impacted the transplantation market. Innovations in surgical techniques, such as minimally invasive and robotic-assisted surgeries, have improved the precision and outcomes of transplant procedures. The development of advanced immunosuppressive drugs has enhanced the management of transplant rejection and improved graft survival rates. Advances in organ preservation and transportation technologies, such as machine perfusion and cold storage solutions, have extended the viability of donor organs, increasing the success rates of transplants. Additionally, regenerative medicine and stem cell research have opened new possibilities for creating bioengineered organs and tissues, addressing the shortage of donor organs. These technological advancements have expanded the scope and effectiveness of transplantation, driving market growth.

Who Are the Key Stakeholders and What Are Their Needs?

The key stakeholders in the transplantation market include transplant centers, hospitals, organ procurement organizations, pharmaceutical companies, and patients. Transplant centers and hospitals perform transplant procedures and provide post-transplant care, requiring access to high-quality donor organs, advanced surgical tools, and effective immunosuppressive therapies. Organ procurement organizations coordinate the donation and distribution of organs, seeking efficient and reliable organ preservation and transportation solutions. Pharmaceutical companies develop immunosuppressive drugs and other therapies to manage transplant rejection and improve outcomes, requiring robust clinical research and development capabilities. Patients rely on successful transplantation to restore their health and quality of life, seeking access to timely and effective transplant services. Each stakeholder group demands innovative and effective solutions to address the complex challenges of transplantation.

What Is Driving Growth in the Transplantation Market?

The growth in the transplantation market is driven by several factors, including the increasing prevalence of organ failure, advancements in transplantation techniques, and the rising demand for organ transplants. The growing incidence of chronic diseases, such as diabetes, cardiovascular diseases, and liver cirrhosis, has led to an increase in organ failures, driving the demand for transplantation. Advancements in transplantation techniques, such as improved surgical methods and immunosuppressive therapies, have enhanced transplant success rates and expanded the pool of eligible recipients. The rising demand for organ transplants, driven by increasing awareness and acceptance of organ donation, has further fueled market growth. Additionally, government initiatives and funding for transplant programs and research have supported the expansion and development of the transplantation market.

Select Competitors (Total 118 Featured) -

  • Abbott Laboratories, Inc.
  • Acelity LP, Inc.
  • Avioq, Inc.
  • AxoGen, Inc.
  • BD Biosciences
  • BioLife Solutions Inc.
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • Carmat SA
  • Chronix Biomedical
  • Dr. Franz Kohler Chemie GmbH
  • F. Hoffmann-La Roche AG
  • GenDx
  • Histogenics Corporation
  • Illumina, Inc.
  • Luminex Corporation
  • Medipex Limited
  • Miromatrix Medical Inc.
  • Nano Dimension Ltd.
  • Organovo Holdings, Inc.
  • Ortho Clinical Diagnostics
  • Oxford Immunotec Global PLC
  • Pacific Biosciences of California, Inc.
  • Pandorum Technologies Pvt. Ltd.
  • Qiagen NV
  • Siemens Healthineers
  • SynCardia
  • Thermo Fisher Scientific, Inc.
  • Transplant Biomedicals S.L.
  • XVIVO Perfusion AB

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Transplantation - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Chronic Diseases
    • Advancements in Surgical Techniques
    • Growth in Organ Donation Awareness
    • Development of Organ Preservation Technologies
    • Rising Adoption of Minimally Invasive Surgeries
    • Expansion of Transplant Centers and Facilities
    • Innovations in Tissue Engineering and Regenerative Medicine
    • Increasing Funding for Transplant Research
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Organ transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Organ transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Organ transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Tissue transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Tissue transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Tissue transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Tissue Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Tissue Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Tissue Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Immunosuppressive Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Immunosuppressive Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Immunosuppressive Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Preservation Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Preservation Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Preservation Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Transplantation Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Transplant Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Transplant Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Transplant Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Transplantation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Transplantation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Transplantation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Transplantation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Transplantation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Transplantation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Transplantation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Transplantation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Transplantation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Transplantation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Transplantation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Transplantation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Transplantation by Procedure Type - Organ transplantation and Tissue transplantation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Transplantation by Procedure Type - Percentage Breakdown of Value Sales for Organ transplantation and Tissue transplantation for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Transplantation by Product Segment - Tissue Products, Immunosuppressive Drugs and Preservation Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Transplantation by Product Segment - Percentage Breakdown of Value Sales for Tissue Products, Immunosuppressive Drugs and Preservation Solutions for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Transplantation by End-Use - Hospitals, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Transplantation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Transplant Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION